600668 尖峰集团
已收盘 09-04 15:00:00
资讯
新帖
简况
股市必读:尖峰集团新发布《尖峰集团关于子公司获得化学原料药上市申请批准通知书的公告》
证券之星 · 09-03 02:03
股市必读:尖峰集团新发布《尖峰集团关于子公司获得化学原料药上市申请批准通知书的公告》
尖峰集团最新公告:子公司获甲基多巴原料药上市批准
证券之星 · 09-01
尖峰集团最新公告:子公司获甲基多巴原料药上市批准
尖峰集团(600668)披露2026年半年度报告,8月31日股价下跌0.92%
证券之星 · 08-31
尖峰集团(600668)披露2026年半年度报告,8月31日股价下跌0.92%
尖峰集团2026年半年报:投资收益骤降,业绩由盈转亏
蓝鲸财经 · 08-31
尖峰集团2026年半年报:投资收益骤降,业绩由盈转亏
图解尖峰集团中报:第二季度单季净利润同比下降73.51%
证券之星 · 08-30
图解尖峰集团中报:第二季度单季净利润同比下降73.51%
尖峰集团(600668.SH)发布半年度业绩,归母净亏损894.95万元
智通财经 · 08-30
尖峰集团(600668.SH)发布半年度业绩,归母净亏损894.95万元
每周股票复盘:尖峰集团(600668)尖峰药业美阿沙坦拟中标集采
证券之星 · 08-09
每周股票复盘:尖峰集团(600668)尖峰药业美阿沙坦拟中标集采
股市必读:尖峰集团新发布《尖峰集团关于子公司参加国家药品集中采购拟中标的公告》
证券之星 · 08-05
股市必读:尖峰集团新发布《尖峰集团关于子公司参加国家药品集中采购拟中标的公告》
尖峰集团(600668)披露子公司参加国家药品集中采购拟中标公告,8月3日股价上涨1.51%
证券之星 · 08-03
尖峰集团(600668)披露子公司参加国家药品集中采购拟中标公告,8月3日股价上涨1.51%
尖峰集团(600668.SH)子公司获得复方托吡卡胺滴眼液药品注册证书
智通财经 · 08-03
尖峰集团(600668.SH)子公司获得复方托吡卡胺滴眼液药品注册证书
每周股票复盘:尖峰集团(600668)子公司获药品注册证书
证券之星 · 07-26
每周股票复盘:尖峰集团(600668)子公司获药品注册证书
尖峰集团(600668.SH)子公司注射用磷酸特地唑胺获得药品注册证书
智通财经 · 07-24
尖峰集团(600668.SH)子公司注射用磷酸特地唑胺获得药品注册证书
每周股票复盘:尖峰集团(600668)上半年净利预亏700万至1000万元
证券之星 · 07-19
每周股票复盘:尖峰集团(600668)上半年净利预亏700万至1000万元
尖峰集团(600668)披露2026年第一次临时股东会决议公告,7月17日股价下跌2.7%
证券之星 · 07-17
尖峰集团(600668)披露2026年第一次临时股东会决议公告,7月17日股价下跌2.7%
尖峰集团(600668)披露2026年半年度业绩预亏公告,7月14日股价上涨1.84%
证券之星 · 07-14
尖峰集团(600668)披露2026年半年度业绩预亏公告,7月14日股价上涨1.84%
每周股票复盘:尖峰集团(600668)4产品新入国家基药目录
证券之星 · 07-12
每周股票复盘:尖峰集团(600668)4产品新入国家基药目录
尖峰集团(600668)披露子公司4个产品新增进入《国家基本药物目录(2026年版)》,7月10日股价上涨2.72%
证券之星 · 07-10
尖峰集团(600668)披露子公司4个产品新增进入《国家基本药物目录(2026年版)》,7月10日股价上涨2.72%
尖峰集团(600668)披露2026年第一次临时股东会会议资料,7月7日股价下跌6.19%
证券之星 · 07-07
尖峰集团(600668)披露2026年第一次临时股东会会议资料,7月7日股价下跌6.19%
每周股票复盘:尖峰集团(600668)补选汪祥耀为董事
证券之星 · 07-05
每周股票复盘:尖峰集团(600668)补选汪祥耀为董事
尖峰集团(600668)披露2025年年度权益分派实施公告,7月2日股价上涨1.36%
证券之星 · 07-02
尖峰集团(600668)披露2025年年度权益分派实施公告,7月2日股价上涨1.36%
加载更多
公司概况
公司名称:
浙江尖峰集团股份有限公司
所属行业:
非金属矿物制品业
上市日期:
1993-07-28
主营业务:
浙江尖峰集团股份有限公司的主营业务是以建材和医药为主,以健康品、商贸物流、电缆等业务为辅。公司的主要产品是水泥、药品。公司是国家重点支持水泥工业结构调整60家大型企业之一的上市公司,是浙江省“三名”培育试点企业,多次入选“中国建材企业100强”、“中国水泥熟料产能100强”,并获得“绿色低碳—中国水泥金质奖”,报告期,公司被评为“品牌管理五星企业”,“尖峰”品牌被评为“AAAAA品牌”。
发行价格:
1.00
{"stockData":{"symbol":"600668","market":"SH","secType":"STK","nameCN":"尖峰集团","latestPrice":7.48,"timestamp":1788505201000,"preClose":7.45,"halted":0,"volume":3899580,"delay":0,"changeRate":0.004,"floatShares":413000000,"shares":413000000,"eps":-0.52,"marketStatus":"已收盘","change":0.03,"latestTime":"09-04 15:00:00","open":7.45,"high":7.58,"low":7.45,"amount":29359600,"amplitude":0.0174,"askPrice":7.5,"askSize":467,"bidPrice":7.48,"bidSize":168,"shortable":0,"etf":0,"ttmEps":-0.52,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":7.45,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":8.2,"lowLimit":6.71,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":412900594,"isCdr":false,"pbRate":0.57,"roa":"--","roe":"--","epsLYR":1,"committee":-0.005787,"marketValue":3088000000,"turnoverRate":0.0094,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-09-07。","floatMarketCap":3088000000},"requestUrl":"/m/hq/s/600668","defaultTab":"news","newsList":[{"id":"2664845629","title":"股市必读:尖峰集团新发布《尖峰集团关于子公司获得化学原料药上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845629","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845629?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:03","pubTimestamp":1788372197,"startTime":"0","endTime":"0","summary":"公司公告汇总尖峰集团关于子公司获得化学原料药上市申请批准通知书的公告安徽尖峰北卡药业有限公司收到国家药品监督管理局签发的《化学原料药上市申请批准通知书》,申报的化学原料药甲基多巴已获批准注册,可在CDE原辅包登记信息平台显示为A状态,具备在国内市场销售资格。尖峰集团关于召开2026年半年度业绩说明会的公告浙江尖峰集团股份有限公司将于2026年10月12日16:00–17:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0186","BK0235","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664647832","title":"尖峰集团最新公告:子公司获甲基多巴原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664647832","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664647832?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:45","pubTimestamp":1788252348,"startTime":"0","endTime":"0","summary":"尖峰集团(600668.SH)公告称,公司下属子公司安徽尖峰北卡药业有限公司收到国家药监局关于化学原料药甲基多巴的《化学原料药上市申请批准通知书》,表明该原料药已符合国家相关审评技术标准,可在国内市场销售,有助于拓展子公司业务领域。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100028939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0186","600668","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663729430","title":"尖峰集团(600668)披露2026年半年度报告,8月31日股价下跌0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663729430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663729430?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:44","pubTimestamp":1788173058,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,尖峰集团报收于7.51元,较前一交易日下跌0.92%,最新总市值为31.01亿元。该股当日开盘7.6元,最高7.65元,最低7.48元,成交额达3211.42万元,换手率为1.03%。尖峰集团于近日披露《2026年半年度报告》。公告显示,公司总资产为786,885.57万元,较上年度末增长0.98%;归属于上市公司股东的净资产为540,303.34万元,较上年度末减少1.85%。经营活动产生的现金流量净额为5,493.42万元,同比减少0.90%。加权平均净资产收益率为-0.16%,较上年同期减少11.45个百分点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0188","600668","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029200","title":"尖峰集团2026年半年报:投资收益骤降,业绩由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029200","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663029200?lang=zh_cn&edition=full","pubTime":"2026-08-31 11:14","pubTimestamp":1788146041,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月31日讯,8月30日,尖峰集团 公布2026年中报,公司依托建材与医药双主业架构,受制于水泥行业需求深跌及医药板块政策承压,报告期业绩出现大幅下滑并陷入亏损;同时,投资收益因上年同期高基数效应消失而显著回落,成为拖累利润的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143007345469445","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0235","BK0188","600668","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663604902","title":"图解尖峰集团中报:第二季度单季净利润同比下降73.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663604902","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663604902?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:39","pubTimestamp":1788082741,"startTime":"0","endTime":"0","summary":"证券之星消息,尖峰集团2026年中报显示,上半年度公司主营收入11.65亿元,同比下降10.33%;归母净利润-894.95万元,同比下降101.45%;扣非净利润-1261.98万元,同比上升76.85%;其中2026年第二季度,公司单季度主营收入6.28亿元,同比下降12.17%;单季度归母净利润937.05万元,同比下降73.51%;单季度扣非净利润610.11万元,同比下降82.47%;负债率27.42%,投资收益1854.82万元,财务费用1491.78万元,毛利率17.15%。财报数据概要请见下图:本文数据来源于尖峰集团2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663229049","title":"尖峰集团(600668.SH)发布半年度业绩,归母净亏损894.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663229049","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663229049?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:21","pubTimestamp":1788081673,"startTime":"0","endTime":"0","summary":"智通财经APP讯,尖峰集团(600668.SH)发布2026年半年度报告,报告期内,公司实现营业收入11.65亿元,同比下降10.33%;归属于上市公司股东的净亏损894.95万元,同比由盈转亏;归属于上市公司股东的扣除非经常性损益的净亏损1261.98万元;基本每股收益-0.0218元。报告期,公司围绕“强化市场导向,创新机制方法,培育竞争优势”的工作总方针,稳定推进各项生产经营工作。上半年,公司建材和医药两大主业都面临激烈的市场竞争,公司收入、利润双双下滑,毛利率下降,净利润出现亏损。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"尖峰集团(600668.SH)发布半年度业绩,归母净亏损894.95万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0186","BK0235","BK0188","600668"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675168","title":"每周股票复盘:尖峰集团(600668)尖峰药业美阿沙坦拟中标集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658675168?lang=zh_cn&edition=full","pubTime":"2026-08-09 03:01","pubTimestamp":1786215674,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,尖峰集团报收于7.42元,较上周的7.29元上涨1.78%。本周,尖峰集团8月4日盘中最高价报7.45元。公司公告汇总尖峰集团全资子公司浙江尖峰药业有限公司参与第十二批国家药品集中采购投标,其美阿沙坦口服常释剂型拟中标,适用于成人原发性高血压治疗,规格为按CHNO计80mg和40mg,采购周期至2029年12月31日。该产品于2026年5月取得药品注册证书,目前无销售收入,后续签订合同情况及业绩影响存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0186","600668","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563060","title":"股市必读:尖峰集团新发布《尖峰集团关于子公司参加国家药品集中采购拟中标的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563060?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:27","pubTimestamp":1785868029,"startTime":"0","endTime":"0","summary":"公司公告汇总尖峰集团关于子公司参加国家药品集中采购拟中标的公告浙江尖峰药业有限公司参加第十二批国家药品集中采购投标,其美阿沙坦口服常释剂型拟中标。尖峰集团关于子公司获得药品注册证书的公告浙江尖峰药业有限公司收到国家药品监督管理局核准签发的复方托吡卡胺滴眼液《药品注册证书》,批准注册,具备生产销售资格。该药品用于诊断及治疗为目的的散瞳和调节麻痹,已列入国家医保和基本药物目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0235","BK0188","600668"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327238","title":"尖峰集团(600668)披露子公司参加国家药品集中采购拟中标公告,8月3日股价上涨1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327238?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:52","pubTimestamp":1785750777,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,尖峰集团报收于7.4元,较前一交易日上涨1.51%,最新总市值为30.55亿元。该股当日开盘7.28元,最高7.42元,最低7.27元,成交额达3306.88万元,换手率为1.09%。近日,尖峰集团发布《关于子公司参加国家药品集中采购拟中标的公告》。公告显示,2026年7月31日,公司全资子公司浙江尖峰药业有限公司参加了第十二批国家药品集中采购投标,其美阿沙坦口服常释剂型拟中标。该产品于2026年5月取得药品注册证书,目前无销售收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300025034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0188","BK0186","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329978","title":"尖峰集团(600668.SH)子公司获得复方托吡卡胺滴眼液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329978","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656329978?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:44","pubTimestamp":1785743052,"startTime":"0","endTime":"0","summary":"智通财经APP讯,尖峰集团(600668.SH)发布公告,近日,公司的全资子公司浙江尖峰药业有限公司收到国家药品监督管理局核准签发的复方托吡卡胺滴眼液《药品注册证书》。托吡卡胺为托品酸的合成衍生物,为M胆碱受体阻断药,作用类似阿托品。去氧肾上腺素是肾上腺素α受体兴奋药,具有散瞳作用。本品用于诊断及治疗为目的的散瞳和调节麻痹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"尖峰集团(600668.SH)子公司获得复方托吡卡胺滴眼液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0235","BK0188","600668","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654762057","title":"每周股票复盘:尖峰集团(600668)子公司获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2654762057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654762057?lang=zh_cn&edition=full","pubTime":"2026-07-26 03:09","pubTimestamp":1785006552,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,尖峰集团报收于7.0元,较上周的7.22元下跌3.05%。本周,尖峰集团7月20日盘中最高价报7.36元。本周关注点来自公司公告汇总:子公司尖峰药业获注射用磷酸特地唑胺药品注册证书。来自公司公告汇总:该药品适用于治疗敏感革兰氏阳性菌引起的皮肤感染。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600001043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","BK0235","600668"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653079007","title":"尖峰集团(600668.SH)子公司注射用磷酸特地唑胺获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2653079007","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653079007?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:26","pubTimestamp":1784881589,"startTime":"0","endTime":"0","summary":"智通财经APP讯,尖峰集团(600668.SH)发布公告,近日,公司全资子公司浙江尖峰药业有限公司收到国家药品监督管理局核准签发的注射用磷酸特地唑胺《药品注册证书》。磷酸特地唑胺适用于治疗由下列革兰氏阳性菌的敏感分离株引起的急性细菌性皮肤及皮肤软组织感染(ABSSSI):金黄色葡萄球菌(包括甲氧西林耐药金黄色葡萄球菌[MRSA]和甲氧西林敏感金黄色葡萄球菌[MSSA]的分离株)、化脓性链球菌、无乳链球菌、咽峡炎链球菌群(包括咽峡炎链球菌、中间链球菌和星座链球菌)和粪肠球菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"尖峰集团(600668.SH)子公司注射用磷酸特地唑胺获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0235","600668","BK0188","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230714","title":"每周股票复盘:尖峰集团(600668)上半年净利预亏700万至1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230714","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230714?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:04","pubTimestamp":1784401455,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,尖峰集团报收于7.22元,较上周的7.17元上涨0.7%。本周,尖峰集团7月17日盘中最高价报7.5元。本周关注点业绩披露要点:尖峰集团预计2026年上半年归属净利润亏损700万元至1000万元,扣非后亏损900万元至1300万元。公司公告汇总尖峰集团2026年半年度业绩预亏公告显示,公司预计2026年半年度归属于上市公司股东的净利润为-1,000万元到-700万元,与上年同期相比由盈转亏;扣除非经常性损益后的净利润预计为-1,300万元到-900万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0235","600668","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289294","title":"尖峰集团(600668)披露2026年第一次临时股东会决议公告,7月17日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652289294?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:37","pubTimestamp":1784299031,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,尖峰集团报收于7.22元,较前一交易日下跌2.7%,最新总市值为29.81亿元。该股当日开盘7.42元,最高7.5元,最低7.13元,成交额达4762.73万元,换手率为1.58%。尖峰集团于近日发布《2026年第一次临时股东会决议公告》。公告显示,公司于2026年7月17日召开2026年第一次临时股东会,会议由董事会召集,董事长蒋晓萌主持,采用现场与网络投票方式召开。出席会议的股东及代理人共316人,代表有表决权股份总数的17.9239%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","600668","BK0235","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651494102","title":"尖峰集团(600668)披露2026年半年度业绩预亏公告,7月14日股价上涨1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651494102","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651494102?lang=zh_cn&edition=full","pubTime":"2026-07-14 23:03","pubTimestamp":1784041396,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,尖峰集团报收于7.18元,较前一交易日上涨1.84%,最新总市值为29.65亿元。该股当日开盘7.0元,最高7.22元,最低6.99元,成交额达2930.36万元,换手率为0.99%。近日,尖峰集团发布《2026年半年度业绩预亏公告》。业绩预亏主要由于水泥市场需求下滑、产品售价下跌导致收入下降,医药板块受医保控费和集采政策影响销售价格下行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400050190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0188","600668","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154661","title":"每周股票复盘:尖峰集团(600668)4产品新入国家基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154661","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154661?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:20","pubTimestamp":1783794020,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,尖峰集团报收于7.17元,较上周的7.58元下跌5.41%。本周,尖峰集团7月6日盘中最高价报7.85元。近日,国家卫生健康委员会等部门发布《国家基本药物目录》。公司全资子公司浙江尖峰药业有限公司及下属子公司共有4个产品新增进入该目录,分别为他氟前列素滴眼液、罗沙司他胶囊、艾司奥美拉唑镁肠溶干混悬剂、对乙酰氨基酚栓。本次入选将有利于产品市场拓展,但短期内不会对公司经营业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0186","BK0235","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650135264","title":"尖峰集团(600668)披露子公司4个产品新增进入《国家基本药物目录(2026年版)》,7月10日股价上涨2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650135264","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650135264?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:26","pubTimestamp":1783693578,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,尖峰集团报收于7.17元,较前一交易日上涨2.72%,最新总市值为29.6亿元。该股当日开盘6.98元,最高7.3元,最低6.88元,成交额达5889.3万元,换手率为2.0%。近日,国家卫生健康委员会等部门发布《国家基本药物目录》。浙江尖峰集团股份有限公司全资子公司浙江尖峰药业有限公司及其下属子公司共有4个产品新增进入该目录,分别为他氟前列素滴眼液、罗沙司他胶囊、艾司奥美拉唑镁肠溶干混悬剂、对乙酰氨基酚栓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0235","600668","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649935467","title":"尖峰集团(600668)披露2026年第一次临时股东会会议资料,7月7日股价下跌6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649935467","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649935467?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:35","pubTimestamp":1783434917,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘,尖峰集团报收于7.27元,较前一交易日下跌6.19%,最新总市值为30.02亿元。近日,尖峰集团发布《2026年第一次临时股东会会议资料》公告。公告显示,公司将于2026年7月17日召开2026年第一次临时股东会,会议采用现场与网络投票相结合的方式,股权登记日为2026年7月10日。董事会提名汪祥耀先生为第十二届董事会非独立董事候选人,任期至本届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700041825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0235","BK0188","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969278","title":"每周股票复盘:尖峰集团(600668)补选汪祥耀为董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969278","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649969278?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:30","pubTimestamp":1783197032,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,尖峰集团报收于7.58元,较上周的7.35元上涨3.13%。本周,尖峰集团6月29日盘中最高价报7.71元。来自尖峰集团2025年年度权益分派实施公告:每股派发现金红利0.10元(含税),股权登记日为2026年7月8日。公司公告汇总尖峰集团于2026年6月30日召开第十二届董事会第17次会议,审议通过《关于补选公司董事的议案》,提名汪祥耀先生为非独立董事候选人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","600668","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648868622","title":"尖峰集团(600668)披露2025年年度权益分派实施公告,7月2日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648868622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648868622?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:59","pubTimestamp":1783004353,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,尖峰集团报收于7.45元,较前一交易日上涨1.36%,最新总市值为30.76亿元。该股当日开盘7.32元,最高7.64元,最低7.26元,成交额达7522.19万元,换手率为2.44%。近日,尖峰集团发布《2025年年度权益分派实施公告》。股权登记日为2026年7月8日,除权(息)日和现金红利发放日均为2026年7月9日。公司回购专用账户股份不参与分配。个人股东持股期限不同,税负分别为20%、10%或免税;QFII及沪港通投资者按10%税率代扣所得税。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","BK0235","600668"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788583935934,"stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0247},{"period":"3month","weight":-0.0199},{"period":"6month","weight":-0.3178},{"period":"1year","weight":-0.3495},{"period":"ytd","weight":-0.3287}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江尖峰集团股份有限公司","boardCode":"AI0030","boardName":"非金属矿物制品业","stockholders":"35109人(较上一季度减少3.15%)","perCapita":"11760股","listingDate":"1993-07-28","address":"浙江省金华市婺城区婺江东路88号","registeredCapital":"41290万元","survey":" 浙江尖峰集团股份有限公司的主营业务是以建材和医药为主,以健康品、商贸物流、电缆等业务为辅。公司的主要产品是水泥、药品。公司是国家重点支持水泥工业结构调整60家大型企业之一的上市公司,是浙江省“三名”培育试点企业,多次入选“中国建材企业100强”、“中国水泥熟料产能100强”,并获得“绿色低碳—中国水泥金质奖”,报告期,公司被评为“品牌管理五星企业”,“尖峰”品牌被评为“AAAAA品牌”。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"尖峰集团(600668)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供尖峰集团(600668)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"尖峰集团,600668,尖峰集团股票,尖峰集团股票老虎,尖峰集团股票老虎国际,尖峰集团行情,尖峰集团股票行情,尖峰集团股价,尖峰集团股市,尖峰集团股票价格,尖峰集团股票交易,尖峰集团股票购买,尖峰集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"尖峰集团(600668)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供尖峰集团(600668)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}